Acalabrutinib
Drug timelines are a Plus or Pro feature.
57 regulatory and trial events tracked for Acalabrutinib, covering 2019-09-12 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia [Phase 3]